Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955589944> ?p ?o ?g. }
Showing items 1 to 77 of
77
with 100 items per page.
- W2955589944 endingPage "13" @default.
- W2955589944 startingPage "5" @default.
- W2955589944 abstract "Objective. The aim of the study was to evaluate the effectiveness of the hypolipidemic therapy with Rosuvastatin in patients, suffering from ischemic heart disease (IHD), II-III class stable angina, and to estimate the risk of IHD development among the inhabitants of Central Russia taking into account carriers of APOE rs7412 gene variant. Materials and methods. We participated 144 patients in pharmacogenetic study, aged 40-70 years, who were prescribed Rosuvastatin in initial dose 5 mg daily with gradual increase up to 10-20-40 mg to attain the target lipid levels in accordance with national recommendations. To estimate IHD risk we used 669 DNA samples, taken from IHD patients and relatively healthy individuals. We estimated the association between genotype and hypolipidemic effect of Rosuvastatin in IHD patients using linear regression, corrected by sex, age, body mass index (BMI), and Rosuvastatin dose. The influence of genotype on IHD risk was estimated using logistic regression. Results. The presence of APOE rs7412 C/T and T/T genotypes was associated with decreased IHD risk (OR=0.51 95% CI 0.30-0.87, P =0.013). IHD patients, being homozygotes in rs7412 had higher initial total cholesterol (TC) levels ( P =0.049) in interaction with age and BMI. T/T genotype was associated with increased response to Rosuvastatin in terms of TC in 1 month ( P =0.0022) and 12 months of therapy ( P =0.037), and in terms of low-density lipoprotein cholesterol (LDL-C) in 1 ( P =0.0018) and 6 months ( P =0.043). Conclusion. We have found the association between APOE rs7412 polymorphism and hypolipidemic effect of Rosuvastatin in IHD patients, and IHD risk in inhabitants of Central Russia." @default.
- W2955589944 created "2019-07-12" @default.
- W2955589944 creator A5005801341 @default.
- W2955589944 creator A5006194014 @default.
- W2955589944 creator A5025188584 @default.
- W2955589944 creator A5047595957 @default.
- W2955589944 creator A5062417996 @default.
- W2955589944 creator A5064106808 @default.
- W2955589944 creator A5073322825 @default.
- W2955589944 date "2019-01-01" @default.
- W2955589944 modified "2023-10-05" @default.
- W2955589944 title "Полиморфный вариант rs7412 гена APOE как маркер риска развития ишемической болезни сердца и эффективности терапии розувастатином" @default.
- W2955589944 doi "https://doi.org/10.21626/vestnik/2019-1/01" @default.
- W2955589944 hasPublicationYear "2019" @default.
- W2955589944 type Work @default.
- W2955589944 sameAs 2955589944 @default.
- W2955589944 citedByCount "0" @default.
- W2955589944 crossrefType "journal-article" @default.
- W2955589944 hasAuthorship W2955589944A5005801341 @default.
- W2955589944 hasAuthorship W2955589944A5006194014 @default.
- W2955589944 hasAuthorship W2955589944A5025188584 @default.
- W2955589944 hasAuthorship W2955589944A5047595957 @default.
- W2955589944 hasAuthorship W2955589944A5062417996 @default.
- W2955589944 hasAuthorship W2955589944A5064106808 @default.
- W2955589944 hasAuthorship W2955589944A5073322825 @default.
- W2955589944 hasBestOaLocation W29555899441 @default.
- W2955589944 hasConcept C104317684 @default.
- W2955589944 hasConcept C126322002 @default.
- W2955589944 hasConcept C135763542 @default.
- W2955589944 hasConcept C151956035 @default.
- W2955589944 hasConcept C2776839432 @default.
- W2955589944 hasConcept C2778425758 @default.
- W2955589944 hasConcept C2779134260 @default.
- W2955589944 hasConcept C2780221984 @default.
- W2955589944 hasConcept C2780499067 @default.
- W2955589944 hasConcept C500558357 @default.
- W2955589944 hasConcept C54355233 @default.
- W2955589944 hasConcept C57089818 @default.
- W2955589944 hasConcept C71924100 @default.
- W2955589944 hasConcept C86803240 @default.
- W2955589944 hasConcept C90924648 @default.
- W2955589944 hasConceptScore W2955589944C104317684 @default.
- W2955589944 hasConceptScore W2955589944C126322002 @default.
- W2955589944 hasConceptScore W2955589944C135763542 @default.
- W2955589944 hasConceptScore W2955589944C151956035 @default.
- W2955589944 hasConceptScore W2955589944C2776839432 @default.
- W2955589944 hasConceptScore W2955589944C2778425758 @default.
- W2955589944 hasConceptScore W2955589944C2779134260 @default.
- W2955589944 hasConceptScore W2955589944C2780221984 @default.
- W2955589944 hasConceptScore W2955589944C2780499067 @default.
- W2955589944 hasConceptScore W2955589944C500558357 @default.
- W2955589944 hasConceptScore W2955589944C54355233 @default.
- W2955589944 hasConceptScore W2955589944C57089818 @default.
- W2955589944 hasConceptScore W2955589944C71924100 @default.
- W2955589944 hasConceptScore W2955589944C86803240 @default.
- W2955589944 hasConceptScore W2955589944C90924648 @default.
- W2955589944 hasIssue "1" @default.
- W2955589944 hasLocation W29555899441 @default.
- W2955589944 hasLocation W29555899442 @default.
- W2955589944 hasOpenAccess W2955589944 @default.
- W2955589944 hasPrimaryLocation W29555899441 @default.
- W2955589944 hasRelatedWork W1471936343 @default.
- W2955589944 hasRelatedWork W2000499274 @default.
- W2955589944 hasRelatedWork W2043355960 @default.
- W2955589944 hasRelatedWork W2054150405 @default.
- W2955589944 hasRelatedWork W2379084044 @default.
- W2955589944 hasRelatedWork W2411149122 @default.
- W2955589944 hasRelatedWork W2913924395 @default.
- W2955589944 hasRelatedWork W3177904351 @default.
- W2955589944 hasRelatedWork W335220206 @default.
- W2955589944 hasRelatedWork W4380083496 @default.
- W2955589944 isParatext "false" @default.
- W2955589944 isRetracted "false" @default.
- W2955589944 magId "2955589944" @default.
- W2955589944 workType "article" @default.